These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 30113139

  • 1. Discovery of a Potent, Long-Acting, and CNS-Active Inhibitor (BIA 10-2474) of Fatty Acid Amide Hydrolase.
    Kiss LE, Beliaev A, Ferreira HS, Rosa CP, Bonifácio MJ, Loureiro AI, Pires NM, Palma PN, Soares-da-Silva P.
    ChemMedChem; 2018 Oct 22; 13(20):2177-2188. PubMed ID: 30113139
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. (4-Phenoxyphenyl)tetrazolecarboxamides and related compounds as dual inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Holtfrerich A, Hanekamp W, Lehr M.
    Eur J Med Chem; 2013 May 22; 63():64-75. PubMed ID: 23455058
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Discovery of Isatin-Based Carbohydrazones as Potential Dual Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase.
    Jaiswal S, Ayyannan SR.
    ChemMedChem; 2022 Jan 05; 17(1):e202100559. PubMed ID: 34637598
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10-2474.
    Bonifácio MJ, Sousa F, Aires C, Loureiro AI, Fernandes-Lopes C, Pires NM, Palma PN, Moser P, Soares-da-Silva P.
    Br J Pharmacol; 2020 May 05; 177(9):2123-2142. PubMed ID: 31901141
    [Abstract] [Full Text] [Related]

  • 17. Pyrazole phenylcyclohexylcarbamates as inhibitors of human fatty acid amide hydrolases (FAAH).
    Aghazadeh Tabrizi M, Baraldi PG, Ruggiero E, Saponaro G, Baraldi S, Romagnoli R, Martinelli A, Tuccinardi T.
    Eur J Med Chem; 2015 Jun 05; 97():289-305. PubMed ID: 26002335
    [Abstract] [Full Text] [Related]

  • 18. Discovery of a potent, selective, and efficacious class of reversible alpha-ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesics.
    Boger DL, Miyauchi H, Du W, Hardouin C, Fecik RA, Cheng H, Hwang I, Hedrick MP, Leung D, Acevedo O, Guimarães CR, Jorgensen WL, Cravatt BF.
    J Med Chem; 2005 Mar 24; 48(6):1849-56. PubMed ID: 15771430
    [Abstract] [Full Text] [Related]

  • 19. Global Portrait of Protein Targets of Metabolites of the Neurotoxic Compound BIA 10-2474.
    Huang Z, Ogasawara D, Seneviratne UI, Cognetta AB, Am Ende CW, Nason DM, Lapham K, Litchfield J, Johnson DS, Cravatt BF.
    ACS Chem Biol; 2019 Feb 15; 14(2):192-197. PubMed ID: 30702848
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo pharmacological characterization of ASP8477: A novel highly selective fatty acid amide hydrolase inhibitor.
    Watabiki T, Tsuji N, Kiso T, Ozawa T, Narazaki F, Kakimoto S.
    Eur J Pharmacol; 2017 Nov 15; 815():42-48. PubMed ID: 29017758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.